ENDRA Life Sciences (NDRA) Cash & Equivalents Growth (3y) (2019 - 2026)
ENDRA Life Sciences (NDRA) Cash & Equivalents Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 9.06% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -20.26% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 14.02% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 15.43% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 11.37% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 39.74% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -12.51% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | -14.97% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 70.63% |
| 10 | ENDRA Life Sciences | 5.44 Mn | 5.08 Mn | - | -46.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -46.71% |
| Dec 31, 2025 | -46.18% |
| Sep 30, 2025 | -53.73% |
| Jun 30, 2025 | -45.67% |
| Mar 31, 2025 | -33.83% |
| Dec 31, 2024 | -30.11% |
| Sep 30, 2024 | -26.17% |
| Jun 30, 2024 | -23.04% |
| Mar 31, 2024 | -59.31% |
| Dec 31, 2023 | -26.81% |
| Sep 30, 2023 | -4.21% |
| Jun 30, 2023 | 86.03% |
| Mar 31, 2023 | -8.78% |
| Dec 31, 2022 | -7.48% |
| Sep 30, 2022 | 52.16% |
| Jun 30, 2022 | 70.70% |
| Mar 31, 2022 | 22.00% |
| Dec 31, 2021 | 13.50% |
| Sep 30, 2021 | 164.53% |
| Jun 30, 2021 | 85.34% |